ANZUP

ANZUP ANZUP's mission is to conduct clinical trial research to improve below the belt cancers.

22/12/2025

This Christmas, we’re standing with every person who wants more time, more joy, and more life. Not defined by fear but filled with possibility.

That’s why our clinical trials matter. They’re not just about finding answers for the future, they’re helping people today live longer, fuller and more meaningful lives.

Your support makes this possible 👉 https://www.belowthebelt.org.au/anzup-christmas-appeal

Together we can help more people get back to the moments that make life extraordinary and live without fear of cancer.

From all of us at ANZUP to you – Merry Christmas. 🎄💝

At 20, Jack was studying to become a doctor when he was diagnosed with high-risk bladder cancer. Thanks to ANZUP-led res...
15/12/2025

At 20, Jack was studying to become a doctor when he was diagnosed with high-risk bladder cancer.

Thanks to ANZUP-led research, he accessed a safer and more effective treatment that helped him keep studying, keep moving, and keep living.

Today, Jack has finished his final exams and is just weeks away from graduating medical school! 🎓👨‍⚕️

Support the research that helps young people like Jack keep moving forward. 👉Donate now: https://www.belowthebelt.org.au/anzup-christmas-appeal

ANZUP is horrified and deeply saddened by the events that occurred in Bondi on Sunday 14  December. ANZUP has zero toler...
15/12/2025

ANZUP is horrified and deeply saddened by the events that occurred in Bondi on Sunday 14 December.

ANZUP has zero tolerance for anti-social and antisemitic behaviour in any form.

We stand together with the Jewish community in disgust and wrap our arms and hearts around all people affected. ❤️

08/12/2025

The day before her daughter’s 16th birthday, Juliet was told she had a rare and aggressive kidney cancer and less than a year to live. 💔

Seven years on, she’s celebrating Christmas cancer-free, surrounded by family, music, and her beloved greyhounds. 👏🎉

An ANZUP clinical trial saved her life.

This Christmas, you can help make more stories like hers possible. 🎄

🔗Donate now: https://www.belowthebelt.org.au/anzup-christmas-appeal

🎤🌟Meet Michael Shafar – a comedian, writer, and all-round good human who’s faced testicular cancer not once, but twice. ...
02/12/2025

🎤🌟Meet Michael Shafar – a comedian, writer, and all-round good human who’s faced testicular cancer not once, but twice.

Through treatment, recurrence, and the anxiety of constant scans, Michael held onto the things that made him feel like him - writing jokes, staying on stage, laughing loudly, and living fully.

Cancer has changed him, but it hasn’t stopped him from living his best life. Now, he’s planning for the future again, without fear of cancer. And behind his story is cancer research that gave him options, time, and the hope to plan for the future. 💖

This Christmas, you can help more people like Michael keep dreaming, hoping, and living fully.

Donate today to support ANZUP’s lifesaving research 👉 https://www.belowthebelt.org.au/anzup-christmas-appeal

📢✨📘We’re excited to share the latest issue of A Little Below the Belt, your go-to source for everything happening in the...
27/11/2025

📢✨📘We’re excited to share the latest issue of A Little Below the Belt, your go-to source for everything happening in the world of Below the Belt cancers.

👇Here’s a taste 👇
- Meet the leaders shaping the fight against Below the Belt cancers.
- Quick guides to symptoms, risk factors, and treatment options.
- Real patient stories that inspire, inform, and remind us why research matters.
- ANZUP in action – see how clinical trials are changing lives.

Read the full magazine now:https://anzup.org.au/wp-content/uploads/2025/10/BTB-Consumer-Magazine-Layout-2025-v9-pages_hyperlinkedFINAL.pdf

“At 44, I was fit, healthy, and living a great life… then came my stage 4 prostate cancer diagnosis.”Sydney dad of two, ...
12/08/2025

“At 44, I was fit, healthy, and living a great life… then came my stage 4 prostate cancer diagnosis.”

Sydney dad of two, Tim Weale, was living his dream, travelling Australia with his family when subtle symptoms signalled something wasn’t right.

At first, he brushed off changes to his urination and unexpected aches and pains. But soon after, tests revealed an aggressive prostate cancer that had already spread to his bones and lungs.

Since his 2023 diagnosis, Tim has faced hormone therapy, radiation, and chemotherapy with incredible courage - all while continuing to work, make memories with his family, and stay positive. Thanks to treatment, his PSA levels have dropped from 154 to 0.01. 🙌

His journey is a powerful reminder to listen to your body, get checked, and live every moment fully.

👉 Learn more about how ANZUP supports research into prostate cancer: https://ow.ly/AZa550WEcpO

Testicular cancer is rare but primarily affects young people aged 15-45. Around 95% of people will survive at least five...
07/08/2025

Testicular cancer is rare but primarily affects young people aged 15-45. Around 95% of people will survive at least five years after their initial diagnosis.

Treatments for testicular cancer are highly effective for most people affected, but sometimes these treatments can lead to challenges like fatigue, muscle loss, reduced s*x drive, anxiety and effects on body image. That's why ANZUP is committed to advancing research to improve both survival and quality of life for those affected.

🔬 Our current clinical trials include:

CLIMATE: Investigating a new blood test (miR-371a-3p) to detect residual disease after surgery, aiming to better personalise the management of disease.

P3BEP: Comparing accelerated versus standard chemotherapy schedules to enhance outcomes for patients with advanced germ cell tumors.

TIGER: Evaluating high-dose chemotherapy and stem cell transplant for relapsed or refractory germ cell tumors.

👉 Learn more about our testicular cancer trials: https://anzup.org.au/clinical-trials/testicular-cancer-trials/

📢 Just published in The Lancet Oncology!Predictive and prognostic value of baseline PSMA-PET total tumor volume (TTV) an...
30/07/2025

📢 Just published in The Lancet Oncology!

Predictive and prognostic value of baseline PSMA-PET total tumor volume (TTV) and SUVmean within a randomised phase 2 trial of enzalutamide versus enzalutamide plus [177Lu] Lu-PSMA-617 (ANZUP1901)

Earlier this year, the ENZA-p trial received global recognition for showing that combining LuPSMA with enzalutamide helps people with high-risk metastatic castrate resistant prostate cancer live longer, better lives.

In this sub-study, Prof Louise Emmett and team show that PSMA-PET total tumour volume is
✅ Prognostic of overall survival with enzalutamide alone
✅ Predictive of improved overall survival with the addition of LuPSMA to enzalutamide

PSMA SUVmean was not predictive or prognostic for progression free or overall survival when LuPSMA is administered with enzalutamide.

These findings provide valuable insight into how PSMA-PET imaging can be used for predicting response to therapy.

Congratulations to Prof Emmett and the team on another globally recognised contribution to prostate cancer research! 🎉

🔗 Find out more here: https://ow.ly/4kVN50WxIFA

You’ve heard of clinical trials, but what do they actually involve?Swipe through this quick Q&A to learn:✔️ What clinica...
11/07/2025

You’ve heard of clinical trials, but what do they actually involve?

Swipe through this quick Q&A to learn:
✔️ What clinical trials are
✔️ Why they matter
✔️ Who can take part
✔️ What it’s like to join one

Got more questions? Drop them in the comments below! ⬇️

📣 The ANZUP 2024/25 Annual Report is now available.This year’s report is a powerful reflection of the impact we’ve made ...
07/07/2025

📣 The ANZUP 2024/25 Annual Report is now available.

This year’s report is a powerful reflection of the impact we’ve made together in advancing GU cancer research and care.

Inside, you’ll find:
• Key research milestones
• Insights from our Chair and CEO
• Subcommittee highlights across Below the Belt cancers
• Membership educational events that brought our membership together
• Grants and awards that are fuelling the next wave of innovation
• A snapshot of our financial performance

📖 Read the full report: https://ow.ly/8ENK50Wlqz5

Pe**le cancer is rare - but that doesn’t mean it’s not worth talking about. Know the signs. Start the conversation.And i...
26/06/2025

Pe**le cancer is rare - but that doesn’t mean it’s not worth talking about.

Know the signs. Start the conversation.
And if you want to wear your support with pride (and a little cheek), grab a pair of ANZUP’s iconic socks 🍌🧦

👉 Swipe through to learn more about pe**le cancer
👀 Find out more about the Australian Pe**le Cancer Registry
🔗 https://ow.ly/2jnj50WguKj

**leCancer

Address

Level 8, Health Translation Hub, 55 Botany Street
Sydney, NSW
2031

Alerts

Be the first to know and let us send you an email when ANZUP posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Practice

Send a message to ANZUP:

Share

Share on Facebook Share on Twitter Share on LinkedIn
Share on Pinterest Share on Reddit Share via Email
Share on WhatsApp Share on Instagram Share on Telegram